Grace Therapeutics, Inc. (GRCE)
Grace Therapeutics, Inc. (GRCE) Insider Trading
Directors, officers and holders of more than 10% of GRCE report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 40 most recent of 40 transactions on file: 19 with code P, 0 with code S and 21 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 26, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 66,411 | $1.77 | $117,408 |
| Oct 22, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 21,390 | $1.93 | $41,193 |
| Oct 19, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 4,256 | $1.88 | $8,001 |
| Oct 16, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 36,347 | $1.89 | $68,758 |
| Oct 15, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 23,485 | $1.95 | $45,685 |
| Oct 14, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 11,233 | $1.93 | $21,735 |
| Oct 12, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 7,215 | $2.02 | $14,574 |
| Oct 9, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 5,340 | $2.04 | $10,918 |
| Oct 8, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 2,077 | $2.02 | $4,190 |
| Oct 5, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 1,694 | $2.06 | $3,490 |
| Oct 2, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 20,000 | $2.07 | $41,368 |
| Oct 1, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 38,796 | $2.04 | $78,961 |
| Sep 29, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 7,849 | $2.09 | $16,404 |
| Sep 23, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 5,318 | $2.10 | $11,168 |
| Sep 21, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 9,771 | $2.10 | $20,519 |
| Sep 17, 2026 | Kottayil George | Director | A Award | 12,200 | Not measured | Not measured |
| Sep 17, 2026 | NEUGEBOREN EDWARD | Director | A Award | 12,200 | Not measured | Not measured |
| Sep 17, 2026 | DAVIS A BRIAN | Director | A Award | 0 | Not measured | Not measured |
| Sep 17, 2026 | Kavuru Vimal | Director | A Award | 12,200 | Not measured | Not measured |
| Sep 9, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 5,836 | $2.09 | $12,197 |
| Sep 9, 2026 | Kohli Prashant | Chief Executive Officer | P Purchase | 100,000 | $2.14 | $214,000 |
| Sep 8, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 9,393 | $2.10 | $19,699 |
| Aug 28, 2026 | Kumar Amresh | VP Program Management | A Award | 35,760 | Not measured | Not measured |
| Aug 28, 2026 | DelAversano Robert J | Principal Financial Officer | A Award | 33,660 | Not measured | Not measured |
| Aug 28, 2026 | Kohli Prashant | Chief Executive Officer | A Award | 267,160 | Not measured | Not measured |
| Aug 28, 2026 | Macdonald R. Loch | Chief Medical Officer | A Award | 54,690 | Not measured | Not measured |
| Aug 14, 2026 | Opaleye Management Inc. | 10% Owner | P Purchase | 11,608 | $2.09 | $24,206 |
| Jan 8, 2026 | Kavuru Vimal | Director | A Award | 10,000 | Not measured | Not measured |
| Jan 8, 2026 | Kottayil George | Director | A Award | 10,000 | Not measured | Not measured |
| Jan 8, 2026 | NEUGEBOREN EDWARD | Director | A Award | 10,000 | Not measured | Not measured |
| Jan 8, 2026 | DAVIS A BRIAN | Director | A Award | 10,000 | Not measured | Not measured |
| May 9, 2025 | Kottayil George | Director | A Award | 10,000 | Not measured | Not measured |
| May 9, 2025 | Kavuru Vimal | Director | A Award | 10,000 | Not measured | Not measured |
| May 9, 2025 | DAVIS A BRIAN | Director | A Award | 10,000 | Not measured | Not measured |
| May 9, 2025 | NEUGEBOREN EDWARD | Director | A Award | 10,000 | Not measured | Not measured |
| Apr 14, 2025 | Kohli Prashant | Chief Executive Officer | A Award | 225,400 | Not measured | Not measured |
| Apr 14, 2025 | D'Andrea Carrie | VP Clinical Operations | A Award | 30,000 | Not measured | Not measured |
| Apr 14, 2025 | DelAversano Robert J | Principal Financial Officer | A Award | 20,130 | Not measured | Not measured |
| Apr 14, 2025 | Macdonald R. Loch | Chief Medical Officer | A Award | 40,000 | Not measured | Not measured |
| Apr 14, 2025 | Kumar Amresh | VP Program Management | A Award | 30,000 | Not measured | Not measured |
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.